30 September 2019
Bird & Bird secures win in preliminary injunction patent case before the Düsseldorf Courts
www.twobirds.com/en/news/articles/2019/germany/bird-and-bird-secures-win-in-preliminary-injunction-patent-case-before-the-dusseldorf-courts

On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...

24 May 2019
Can CRISPR save the Cavendish?
www.twobirds.com/en/news/articles/2019/global/can-crispr-save-the-cavendish

The world's most popular banana is dying. Scientists are using the gene-editing mechanism CRISPR to try and save it from extinction.

06 September 2019
China passed new amendments to the Drug Administration Law
www.twobirds.com/en/news/articles/2019/global/china-passed-new-amendments-to-the-drug-administration-law

On 26 August 2019, China's National People's Congress passed the final amendments to the Drug Administration Law ("DAL"), which will take effect on 1 December 2019. The DAL was first enacted in 1984, then substantively ...

03 August 2020
China Updates Drug Registration Rules and the Measures for Monitoring Drug Production – Part 2
www.twobirds.com/en/news/articles/2020/china/china-updates-drug-registration-rules-and-the-measures-for-monitoring-drug

The restating of the expedited review pathways, and the recently published work procedures, appear to be a step toward improving a process that has seemingly changed numerous times over the years.

16 September 2020
NMPA and CNIPA issue Draft Patent Linkage Measures in China
www.twobirds.com/en/news/articles/2020/china/nmpa-and-cnipa-issue-draft-patent-linkage-measures-in-china

On 11 September 2020, the National Medical Products Administration ("NMPA") and the China National Intellectual Property Administration ("CNIPA") issued the draft "Implementing Measures for Drug Patent Dispute Early ...

04 December 2020
Supplemental Protection Period for pharmaceutical patents in China - Update
www.twobirds.com/en/news/articles/2020/china/supplemental-protection-period-for-pharmaceutical-patents-in-china---update

On 27 November 2020, the China National Intellectual Property Administration (“CNIPA”) issued the draft Implementing Regulations of the PRC Patent Law (“Draft Amendments for Implementing Regulations”) for public ...

04 November 2020
Chinese patent linkage system - the Chinese Supreme Court issues Draft Judicial Interpretations
www.twobirds.com/en/news/articles/2020/china/chinese-patent-linkage-system---the-chinese-supreme-court-issues-draft-judicial-interpretations

As the patent linkage provisions are new for China, the Draft Judicial Interpretations provide some guidance on how the system will be implemented in practice. The Draft Judicial Interpretations are open for public ...

15 October 2020
Patent linkage scheme in Singapore – A process patent can be "A patent in respect of the therapeutic product"
www.twobirds.com/en/news/articles/2020/singapore/patent-linkage-scheme-in-singapore

In Singapore, pursuant to the Health Products (Therapeutic Products) Regulations 2016, applicants for registration of a therapeutic product in Singapore must declare whether "a patent is in force in respect of the ...

27 March 2019
Supreme Court holds Dosage Regime Patent Obvious
www.twobirds.com/en/news/articles/2019/global/supreme-court-holds-dosage-regime-patent-obvious

Today in Actavis v ICOS the Supreme Court unanimously ruled that the ICOS patent for a Tadalafil dosing regime was invalid. Lord Hodge gave the only judgment, with Lady Hale, Lord Kerr, Lord Sumption and Lord Briggs in ...

08 May 2019
Manufacturing and stockpiling waiver set to limit rights of holders of SPCs for medicines
www.twobirds.com/en/news/articles/2019/global/manufacturing-and-stockpiling-waiver-set-to-limit-rights-of-holders-of-spcs-for-medicines

On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").